TNGNQ

 
Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 3929 Westpoint Blvd.
  • Suite G
  • Winston-Salem, NC 27103

Business Description

Not Available


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2014 10-Q
CIK 0001296391
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
John Miclot CEO
Brian Davis CFO
Company Directors
Not Available
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Note = On December 29, 2014, Tengion, Inc. commenced a bankruptcy proceeding by filing a voluntary petition for relief under the provisions of chapter 7 of title 11 of the United States Code, 11 U.S.C. SS 101 et seq . in the United States Bankruptcy Court for the District of Delaware. The Chapter 7 Case is being administered under case number 14-12829.
TNGNQ Security Details
Share Structure
Market Value1 $73,240 a/o Mar 24, 2017
Authorized Shares Not Available
Outstanding Shares 36,620,124 a/o Nov 10, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record 145 a/o Mar 26, 2014
Short Selling Data
Short Interest 17 (0%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security